WallStSmart

Nebius Group N.V. (NBIS)vsUpexi Inc. (UPXI)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Nebius Group N.V. generates 5321% more annual revenue ($1.36B vs $25.00M). NBIS leads profitability with a 3.1% profit margin vs 0.0%. NBIS earns a higher WallStSmart Score of 43/100 (D).

NBIS

Hold

43

out of 100

Grade: D

Growth: 8.0Profit: 3.0Value: 6.7Quality: 6.5
Piotroski: 5/9Altman Z: 1.10

UPXI

Avoid

35

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.0Quality: 5.5
Piotroski: 3/9Altman Z: -2.52
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NBISUndervalued (+63.1%)

Margin of Safety

+63.1%

Fair Value

$430.09

Current Price

$171.99

$258.10 discount

UndervaluedFair: $430.09Overvalued

Intrinsic value data unavailable for UPXI.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NBIS2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
454.0%10/10

Revenue surging 454.0% year-over-year

PEG RatioValuation
0.518/10

Growing faster than its price suggests

UPXI2 strengths · Avg: 10.0/10
EPS GrowthGrowth
3573.0%10/10

Earnings expanding 3573.0% YoY

Debt/EquityHealth
-4.1610/10

Conservative balance sheet, low leverage

Areas to Watch

NBIS4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.6%3/10

ROE of 0.6% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

P/E RatioValuation
129.3x2/10

Premium valuation, high expectations priced in

UPXI4 concerns · Avg: 2.8/10
Market CapQuality
$70.54M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-468.5%2/10

ROE of -468.5% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : NBIS

The strongest argument for NBIS centers on Revenue Growth, PEG Ratio. Revenue growth of 454.0% demonstrates continued momentum. PEG of 0.51 suggests the stock is reasonably priced for its growth.

Bull Case : UPXI

The strongest argument for UPXI centers on EPS Growth, Debt/Equity.

Bear Case : NBIS

The primary concerns for NBIS are EPS Growth, Return on Equity, Profit Margin. A P/E of 129.3x leaves little room for execution misses. Thin 3.1% margins leave little buffer for downturns.

Bear Case : UPXI

The primary concerns for UPXI are Market Cap, Profit Margin, Piotroski F-Score.

Key Dynamics to Monitor

NBIS profiles as a hypergrowth stock while UPXI is a value play — different risk/reward profiles.

NBIS carries more volatility with a beta of 1.46 — expect wider price swings.

NBIS is growing revenue faster at 454.0% — sustainability is the question.

UPXI generates stronger free cash flow (-4M), providing more financial flexibility.

Bottom Line

NBIS scores higher overall (43/100 vs 35/100) and 454.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nebius Group N.V.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Nebius Group N.V. (Ticker: NBIS) is an innovative technology firm that specializes in advanced digital solutions to enhance client engagement and operational efficiency across diverse sectors. By integrating cutting-edge cloud computing, artificial intelligence, and data analytics, Nebius enables businesses to adeptly manage the complexities of today's digital landscape. The company boasts a strong portfolio of intellectual property and strategic partnerships, positioning it favorably to capitalize on significant growth opportunities in the technology-driven marketplace. As such, Nebius presents a compelling investment opportunity for institutional investors seeking to gain exposure to pioneering solutions in the tech sector.

Visit Website →

Upexi Inc.

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Grove, Inc., is engaged in the development, production, marketing, and sale of raw materials, private label products, and end-consumer products containing the industrial hemp plant extract, cannabidiol. The company is headquartered in Henderson, Nevada.

Want to dig deeper into these stocks?